Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy
-
* Corresponding author: Duncan Wyncoll duncan.wyncoll@gstt.nhs.uk
Critical Care 2008, 12:R163 doi:10.1186/cc7163
See related commentary by de Pont and Schultz, http://ccforum.com/content/13/1/113
Accesses
- Last 30 days: 39 accesses
- Last 365 days: 475 accesses
- All time: 3225 accesses